BRTX vs TECH
BioRestorative Therapies Inc (BRTX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BRTX currently screens at market cap $10.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BRTX and TECH stock pages for the full models.
Not investment advice.